Mirati Therapeutics (NQ: MRTX )
53.09 +2.03 (+3.98%) Streaming Delayed Price Updated: 4:00 PM EST, Jan 27, 2023 Add to My Watchlist
All News about Mirati Therapeutics
Biotech Sector Witnessing Growing Revenue Potential in Ongoing Battle Against Pancreatic Cancer
November 15, 2022
FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 15, 2022 – USA News Group – Roughly five years after selling its flagship cancer asset Onivyde from to French biotech...